Here are four things to know:
1. Throughout the last few years, DeepMind has been focused on developing artificial intelligence research and mobile tools to improve patient care and clinician workflows.
2. By being completely under Google, DeepMind will leverage the company’s global expertise in app development, data security, cloud storage and user-centered design.
3. Within the U.K., DeepMind has formed partnerships with various academic medical centers and national health foundations. The company has also worked the U.S. Department of Veterans Affairs to improve the detection of patient deterioration.
4. Dr. King understands that a transition like this will take time. DeepMind is giving power to its partners to ask questions and to choose if they want to continue collaborating.
“I know DeepMind is proud of our healthcare work to date. With the expertise and reach of Google behind us, we’ll now be able to develop tools and technology capable of helping millions of patients around the world,” Mr. King said.
More articles on AI:
GE Healthcare’s AI X-ray device 1st to receive FDA clearance
Intel, Nvidia execs say White House plan for $1B AI investment doesn’t go far enough
Geisinger partners with IBM for AI-based sepsis prevention
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
